Tuesday, September 20, 2016

BRIEF-Ampliphi Biosciences provides update on phase 1 trial in chronic rhinosinusitis patients

* Ampliphi Biosciences provides update on phase 1 trial in

chronic rhinosinusitis patients

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)